ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

South Korea · Delayed Price · Currency is KRW

941.00

-33.00 (-3.39%)

At close: Apr 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing and Sales			62.97B	68.88B	57.56B	65.36B	67.54B
Pharmaceutical Manufacturing and Sales Growth			-8.57%	19.66%	-11.93%	-3.22%	7.05%
Total			62.97B	68.88B	57.56B	65.36B	67.54B
Total Growth			-8.57%	19.66%	-11.93%	-3.22%	7.05%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Korea			65.76B	72.04B	60.40B	68.72B	49.40B
Korea Growth			-8.72%	19.27%	-12.11%	39.11%	4.11%
Vietnam			53.37M	83.57M	56.38M	44.08M	-
Vietnam Growth			-36.14%	48.21%	27.91%	-	-
Elimination of Internal Transactions			-2.84B	-3.24B	-2.90B	-3.40B	-
Export			-	-	-	-	5.94B
Export Growth			-	-	-	-	7.81%
Unallocated			-	-	-	-	12.20B
Unallocated Growth			-	-	-	-	20.39%
Total			62.97B	68.88B	57.56B	65.36B	67.54B
Total Growth			-8.57%	19.66%	-11.93%	-3.22%	7.05%

Source: S&P Global Market Intelligence.